The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed an additional purchase of $5.2 million in Impinj Inc $PI.
Patrick J. Heron, director of Mirum Pharmaceuticals $MIRM, revealed a purchase of 147,991 shares, equivalent to $3,884,763.
The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed a purchase of $8 million in Impinj Inc $PI.
The hedge fund now owns 3,869,196 shares, representing an ownership stake of roughly 14%.
Welcome back to Under the Hood, where we'll cover all the action for the week ended August 31, 2023. This report is published bi-weekly and rotated with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.